Vesicular Monoamine Transporter Inhibitors
PDL Reference Documents
PDL Status Values
Y = preferred
N = non-preferred. Non-preferred drugs listed as N but without clinical drug use criteria are subject to the
Non-Preferred Drugs in Select PDL Classes prior authorization criteria.
New drugs will be listed as N until reviewed by the P&T Committee and are subject to the
New Drug Policy.
V = voluntary non-preferred. Non-preferred mental health drugs are listed as V and prior authorization is not required.
Null (i.e. blank) = indicates the class or specific drug has not been reviewed for PDL placement.
To request a Prior Authorization, please use this form.
| Generic Name | Brand Name | Form | PDL Status |
Current Drug Use Criteria | New Drug Evaluation |
|---|---|---|---|---|---|
| deutetrabenazine | AUSTEDO TD TITRATN PK (WK 1-2) | TAB DS PK | N | PA Document | |
| deutetrabenazine | AUSTEDO 12MG START TITR(WK1-4) | TAB DS PK | N | PA Document | |
| deutetrabenazine | AUSTEDO XR | TAB ER 24H | N | PA Document | |
| deutetrabenazine | AUSTEDO XR TITRATION KT(WK1-4) | TAB24HDSPK | N | PA Document | |
| deutetrabenazine | AUSTEDO | TABLET | N | PA Document | |
| tetrabenazine | XENAZINE | TABLET | N | PA Document | |
| tetrabenazine | TETRABENAZINE | TABLET | N | PA Document | |
| valbenazine tosylate | INGREZZA INITIATION PACK | CAP DS PK | N | PA Document | |
| valbenazine tosylate | INGREZZA | CAPSULE | N | PA Document |